divinyl sulfone has been researched along with Parkinson Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bettin, I; Fagagnini, A; Fasoli, S; Gotte, G; Laurents, DV; Montioli, R; Peterle, D | 1 |
| Choi, JW; Kim, BE; Kim, HJ; Kim, S; Lee, EH; Lee, YS; Park, JH; Park, KD; Yoo, JS | 1 |
| Choi, JW; Han, SH; Hwang, O; Jang, BK; Kang, YG; Kim, DJ; Kim, JH; Kim, JW; Lee, J; Moon, MK; Park, KD; Song, HJ; Woo, SY; Yeon, SK | 1 |
3 other study(ies) available for divinyl sulfone and Parkinson Disease
| Article | Year |
|---|---|
Dimerization of Human Angiogenin and of Variants Involved in Neurodegenerative Diseases.
Topics: Amyotrophic Lateral Sclerosis; Chromatography; Crystallography, X-Ray; Dimerization; Genetic Variation; Humans; Models, Molecular; Mutation; Parkinson Disease; Phosphorylation; Protein Conformation; Protein Domains; Ribonuclease, Pancreatic; Ribonucleases; Sulfones | 2021 |
Development and optimization of halogenated vinyl sulfones as Nrf2 activators for the treatment of Parkinson's disease.
Topics: Animals; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Development; Halogenation; Humans; Male; Mice; Mice, Inbred C57BL; Molecular Structure; NF-E2-Related Factor 2; Parkinson Disease; Structure-Activity Relationship; Sulfones | 2021 |
Discovery of vinyl sulfones as a novel class of neuroprotective agents toward Parkinson's disease therapy.
Topics: Animals; Base Sequence; Cell Line; Disease Models, Animal; DNA Primers; Heme Oxygenase-1; Humans; Magnetic Resonance Spectroscopy; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Reverse Transcriptase Polymerase Chain Reaction; Spectrometry, Mass, Electrospray Ionization; Sulfones | 2014 |